The global biopsy devices market has undergone a phenomenal shift in nature due to the growing adoption of guidance based biopsy procedures. Biopsy refers to minimally invasive extraction of suspected abnormality in tissues for pathophysiological testing. The gradual rise in awareness among the patient population and alarming growth in cancer incidence in the global population that bears a high risk of chronic diseases and cancer are observed to be the prime factors that have led to the growth in demand for biopsy devices in the worldwide market.
Based on product types, the global biopsy devices market is studied for guidance systems, biopsy needles, needle-based biopsy guns, biopsy forceps and others (curettes and punches) segments. Biopsy guidance systems market is further studies for robotic and manual guidance systems segments. Additionally, biopsy needles segment is studied for disposable and reusable biopsy needles. Needle based biopsy guns segment is sub-classified into fine needle aspiration, core needle biopsy, and vacuum-assisted biopsy systems markets. The biopsy forceps segment is studied for hot and cold biopsy forceps markets. This report includes market size and forecast for the segments and their sub-markets thus mentioned for the period 2014-2023 (in terms of USD Mn). Additionally, the compounded annual growth rate (CAGR %) for each segment is provided in the study for the period 2016-2023, considering 2015 as the base year.
From the perspective of geographical distribution, the global biopsy devices market is studied for four regional markets namely, North America, Europe, Asia-Pacific and Rest of the World. Each of these regional markets is further studies for the top national and sub-regional markets.
Along with the quantitative information in terms of market size and forecast, this report also includes qualitative market information demonstrating the market trends and future outlook of the biopsy devices industry. This report includes a description of the market dynamics: drivers, challenges, and opportunities, fractal map analysis for competition assessment and attractive investment proposition. This study concludes with company profiles section that includes major information about the key market players operating in the global biopsy devices market.
For the purpose of this study, the global biopsy device market is analyzed for four major segments namely, biopsy guidance systems, biopsy needles, needle based biopsy guns and biopsy forceps, and others. These segments based on their individual product variants are further sub-classified and their market size and forecast are studied in this report.
Among the mentioned segments, biopsy guidance systems segment dominates the market in terms of revenue share. This segment is further categorized into robotic and manual guidance systems markets. Added precision to biopsy procedure aided through guidance systems, better diagnosis outcome and improved accuracy are the major factors supporting the growth of guidance systems market. On the other hand, needle based biopsy guns segment is anticipated to progress with a CAGR close to 8% during 2016-2023. This segment is further categorized into fine needle aspiration, core needle biopsy guns and vacuum assisted biopsy guns markets. Among these, vacuum-assisted biopsy guns segment is undergoing the fastest market growth and is also the largest segment in terms of market size.
North America is the largest geographical market for biopsy devices, followed by Europe. Earliest adoption of latest technologies, widespread use of guidance systems in biopsy procedures and aid from reimbursement policies are the major contributors to the lead of these regions. Rapid development of healthcare infrastructure, coupled with alarming rise in cancer incidence in developing economies of Asia-Pacific will contribute to the rising growth rate of Asia-Pacific and Rest of the World markets. This study also analyzes the global biopsy devices market on major national and sub-regional level.
Historical & Forecast Period
This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.
The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Biopsy Devices market are as follows:
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.
ATTRIBUTE | DETAILS |
---|---|
Research Period | 2022-2032 |
Base Year | 2023 |
Forecast Period | 2024-2032 |
Historical Year | 2022 |
Unit | USD Million |
Segmentation | |
Products
| |
Region Segment (2022-2032; US$ Million)
|
Key questions answered in this report